Early percutaneous coronary intervention after fibrinolysis for acute ST elevation myocardial infarction: results of two German multi‐centre registries (ACOS and GOAL)

References

• The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary‐artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615–22
   PubMed Web of Science ®Google Scholar
• Gibson C. M., Cannon C. P., Murphy S. A., Ryan K. A., Mesley R., Marble S. J., et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000; 101: 125–30
   PubMed Web of Science ®Google Scholar
• Antman E. M., Anbe D. T., Armstrong P. W., Bates E. R., Green L. A., Hand M., et al. ACC/AHA guidelines for the management of patients with ST‐elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). J Am Coll Cardiol 2004; 44: E1–211
   PubMedGoogle Scholar
• Grines G. L., Browne K. F., Marco J., Rothbaum D., Stone G. W., O'Keefe J., et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993; 328: 680–4
   PubMed Web of Science ®Google Scholar
• Morrow D. A., Antman E. M., Parsons L., de Lemos J. A., Cannon C. P., Giugliano R. P., et al. Application of the TIMI risk score for ST‐elevation MI in the National Registry of Myocardial Infarction 3. JAMA 2001; 286: 1356–59
   PubMed Web of Science ®Google Scholar
• Rogers W. J., Baim D. S., Gore J. M., Brown B. G., Roberts R., Williams D. O., et al. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue‐type plasminogen activator. Results of the Thrombolysis in Myocardial infarction (TIMI) Phase II‐A Trial. Circulation 1990; 81: 1457–76
   PubMed Web of Science ®Google Scholar
• Simoons M. L., Arnold A. E., Betriu A., de Bono D. P., Col J., Dougherty F. C., et al. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet 1988; 1: 197–203
   PubMed Web of Science ®Google Scholar
• The TIMI Study group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial infarction (TIMI) Phase II Trial. N Engl J Med 1989; 320: 618–27
   PubMed Web of Science ®Google Scholar
• SWIFT (Should we intervene following thrombolysis?) Trial Study Group. SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. BMJ 1991; 302: 555–60
   PubMedGoogle Scholar
• Michels K. B., Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta‐analysis) of randomised clinical trials. Circulation 1995; 91: 476–85
   PubMed Web of Science ®Google Scholar
• Alfonso F., Rodriguez P., Philipps P., Goicolea J., Hernandez R., Perez‐Vizcayno M. J., et al. Clinical and angiographic implications of coronary stenting in thrombus‐containing lesions. J Am Coll Cardiol 1997; 29: 725–33
   PubMed Web of Science ®Google Scholar
• Stones G. W., Grines C. L., Cox D. A., Garcia E., Tcheng J. E., Griffin J. J., et al. Comparison of angioplasty with stenting, with or without abciximab in acute myocardial infarction. N Engl J Med 2002; 347: 367–68
   PubMed Web of Science ®Google Scholar
• Steinhubl S. R., Berger P. B., Mann J. T 3rd., Fry E. T., DeLago A., Wilmer C., et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomised controlled trial. JAMA 2002; 288: 2411–20
   PubMed Web of Science ®Google Scholar
• Le May M. R., Wells G. A., Labinaz M. Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study). J Am Coll Cardiol 2005; 46: 417–24
   PubMed Web of Science ®Google Scholar
• Scheller B., Hennen B., Hammer B., Walle J., Hofer C., Hilpert V., et al. Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. J Am Coll Cardiol 2003; 42: 634–41
   PubMed Web of Science ®Google Scholar
• Fernandez‐Avilés F., Alonso J. J., Castro‐Beiras A., Vázquez N., Blanco J., Alonsa‐Briales J., , on behalf of the Gracia Group, et al. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia‐guided conservative approach for acute myocardial infarction with ST‐segment elevation (GRACIA‐1): a randomised controlled trial. Lancet 2004; 364: 1045–53
   PubMed Web of Science ®Google Scholar
• Morrow D. A., Antman E. M., Charlesworth A., Cairns R., Murphy S. A., de Lemos J. A., et al. TIMI risk score for ST elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation. Circulation 2000; 102: 2031–7
   PubMed Web of Science ®Google Scholar
• Thiele H., Engelmann L., Elsner K., Kappl M. J., Storch W. H., Rahimi K., et al. Comparison of pre‐hospital combination‐fibrinolysis plus conventional care with pre‐hospital combination‐fibrinolysis plus facilitated percutaneous coronary intervention in acute myocardial infarction. Eur Heart J 2005; 26: 1956–63
   PubMed Web of Science ®Google Scholar
• Waller B. F., Rothbaum D. A., Pinkerton C. A., Cowley M. J., Linnemeier T. J., Orr C., et al. Status of the myocardium and infarct‐related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r‐tissue plasminogen activator), mechanical (percutaneous transluminal coronary angioplasty) or combined types of reperfusion therapy. J Am Coll Cardiol 1987; 9: 785–801
   PubMed Web of Science ®Google Scholar
• Fernandez‐Aviles F., Alonso J. J., Gimeno F., Ramos B., Duran J. M., Bermejo J., et al. Safety of coronary stenting early after thrombolysis in patients with acute myocardial infarction: one‐ and six‐month clinical and angiographic evolution. Cathet Cardiovasc Intervent 2002; 55: 467–76
   PubMed Web of Science ®Google Scholar
• Steinhubl S. R., Berger P. B., Mann J. T., Fry E. T. A., DeLago A., Wilmer C., et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002; 288: 2411–20
   PubMed Web of Science ®Google Scholar
• Sutton A. G., Campbell P. G., Graham R., Price D. J., Gray J. C., Grech E. D., et al. A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST‐segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit Infarction (MERLIN) trial. J Am Coll Cardiol 2004; 44: 287–96
   PubMed Web of Science ®Google Scholar